Design of Peptide-Based Probes for the Microscale Detection of Reactive Oxygen Species.
Reactive oxygen species (ROS) can induce oxidative stress and are associated with cell death and chronic diseases in organisms. In the treatment of disease, drugs that induce ROS are associated with many side effects and unpleasant symptoms. Therefore, during the assessment of new drugs and candidate compounds, ROS generation is an issue of concern, because ROS can modify proteins, lipids, and nucleic acids within organisms and alter their biological functions. In this work, we designed a peptide-based probe for the rapid (<10 min) high-throughput survey of oxidative stress induced by clinical drugs at the microliter level. Using menadione and H2O2 as positive controls, just 100 μg/mL of the test compound and 100 μg/mL of the probe were sufficient to effectively monitor the generation of ROS, which is important as many active compounds are rare and difficult to isolate or purify. This in vitro evaluation could be used to effectively generate preliminary data before pharmacologically active candidate compounds are processed in cell-line or animal tests. Furthermore, we demonstrated that this peptide probe successfully detects ROS in biological samples.